Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI announces enrollment of cohort of people without tuberculosis (TB) infection in Phase 2b trial of TB vaccine candidate MTBVAC

February 23, 2026

Additional enrollment of 1,200 participants could ultimately enable a fast track to licensure

Read more

Features

Ending neglected diseases requires partners willing to go where markets won’t

January 29, 2026

~ An IAVI Statement on World Neglected Tropical Diseases (NTDs) Day 2026 ~

Read more

Features

IAVI and Partners Announce the 8th Global Forum on TB Vaccines in April 2027 in Zaragoza, Spain

January 23, 2026

The 8th Global Forum will take place from April 12-14, 2027—marking a return to the European region and the first time in a Spanish-speaking country

Read more

Features

Epidemiology studies strengthening data management capacity for future Lassa fever vaccine trials in Sierra Leone: a conversation with Foday Alhasan

January 14, 2026

Strengthening data management capacities is helping ensure institutional readiness for future Lassa fever vaccine trials in Sierra Leone

Read more

Features

2025 in Review: HIV Vaccine Research Through the Eyes of African Scientists

December 22, 2025

Researchers leading HIV vaccine research work in Africa offer their perspectives on a turbulent year with global implications.

Read more

Features

The potential of new TB vaccines offers hope at the Union Conference in a year of crisis 

December 10, 2025

The global TB community reaffirmed its commitment to develop and deliver accessible new TB vaccines

Read more

Features

IAVI Statement on World AIDS Day

December 1, 2025

A year of challenge with leaps forward in HIV prevention worth celebrating

Read more

Features

IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025

October 30, 2025

IAVI’s experts underscored the value of equitable, regional partnerships in bringing new vaccines to market at this year’s convening in Amsterdam

Read more